{
    "2020-02-14": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Dow Jones Today: A Day for Safe Havens",
                "features": {
                    "keywords": [
                        "Dow",
                        "Jones",
                        "Safe Havens"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-07-15",
                "original_text": "Drug wholesaler stocks falls after WSJ report that states rejected opioid settlement offer",
                "features": {
                    "keywords": [
                        "Drug",
                        "wholesaler",
                        "stocks",
                        "WSJ",
                        "opioid",
                        "settlement",
                        "rejected"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-02-05",
                "original_text": "Pharma Stock Roundup: ABBV, AGN Post Q4 Results, Another Alzheimer's Study Fails",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "ABBV",
                        "AGN",
                        "Q4",
                        "Results",
                        "Alzheimer's",
                        "Study",
                        "Fails"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-01-21",
                "original_text": "The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Epizyme",
                        "Tazemetostat",
                        "sNDA",
                        "Priority",
                        "Review",
                        "Eisai",
                        "Weight",
                        "Loss",
                        "Drug",
                        "Sol-Gel",
                        "Prices",
                        "Offering"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}